The present invention provides the compounds of formula (I) ##STR00001## their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

 
Web www.patentalert.com

< ABCA1 elevating compounds

> Heterocyclic compounds useful as Nurr-1 activators

~ 00467